Auna Q2 results show revenue growth, cash flow expansion, and leverage improvement
Aug 18, 2026, 4:59 PM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting
Strong top-line growth and cash-flow acceleration support near-term multiple expansion, despite EBITDA headwinds from service mix and Peru penalties; improving leverage provides optionality for deleveraging catalysts.
AI summary
What happened, with direct paths to the underlying reporting
Auna reported 2Q26 revenue of S/1,238 million, up 9% FXN (13% YoY), as volumes recovered in Mexico and growth accelerated in Peru and Colombia. Adjusted EBITDA declined 9% FXN due to service mix and Peru penalties, but operating cash flow surged 45% while free cash flow jumped 181%, supporting a leverage ratio of 3.6x. The company reaffirmed 2026 guidance with roughly 12% FX-neutral revenue growth and a 4% capex target of revenue, signaling a pathway toward deleveraging.
2Q26 revenue rose 9% FXN to S/1,238m, +13% YoY.
Adjusted EBITDA 227m, down 9% FXN; margin 18.4%.
OCF up 45% YoY; FCF up 181% YoY; leverage 3.6x.
Surgeries 21,912 (+5.2%); hospital days 135,107 (+5%); Chemo/RT +15%.
Guidance reaffirmed: revenue ~12% FX-neutral growth; Capex ~4% of revenue.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event